Skip to Content

Health

FDA clears first digital treatment for depression, but experts caution that research is still early

By Mira Cheng, CNN (CNN) — The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, is a smartphone app intended for use alongside antidepressant medications for people 22 and older who have a diagnosis of

Continue Reading

LGBT adults in the US are twice as likely to experience disrespect or unfair treatment at the doctor’s office, survey finds

By Deidre McPhillips, CNN (CNN) — The disproportionate level of discrimination that LGBT adults experience in their daily lives extends to the doctor’s office, and these negative experiences have led many to change their health care and behavior, a new survey from KFF found. A third of LGBT adults say that a doctor or another

Continue Reading

CNN Exclusive: Adderall prescriptions have been filled less often amid ongoing shortage in the US

By Deidre McPhillips, CNN (CNN) — About 1 in every 10 people in the US who uses Adderall or similar combination drugs to treat attention-deficit/hyperactivity disorder (ADHD) has been affected by an ongoing shortage, a new analysis suggests. The US Food and Drug Administration announced that Adderall was in shortage in mid-October 2022, and the share of

Continue Reading
Skip to content